QA: Pulmatrix Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001574235_2015_Pulmatrix_Inc.pdf

Logs

warning Expenses in unusual place in relation to revenue input.sec.calculation_linkbase.edgar_model_mapping {'expenses_node': 'OperatingExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'}

Graph

Absolute values for 0001574235, Pulmatrix Inc

  xvar xval
0 AssetsCurrent 15,574,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,000
3 remainder_Assets 0
4 LiabilitiesCurrent 947,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,736,000
9 ResearchAndDevelopmentExpense 1,382,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,576,000
1 Liabilities 947,000
2 Expenses 3,118,000
3 Revenues 0
4 StockholdersEquity 14,629,000
5 NetIncome -3,118,000
6 ComprehensiveNetIncome -3,118,000
7 BaseVar 9,820,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.48
9 EconomicCapitalRatio 4.02

Edgar->Model Mapping

Feature Distribution